The voice of people

with MS in Europe

MS and the EU

Cross-border treatment made easier for EU patients by new Directive

 

The "Cross-border healthcare" Directive, entered into force on 25 October 2013, gives European citizens the right to receive medical treatment across the EU, and to be reimbursed for it.


The new Directive introduces three major changes focusing on patients' rights, according to the European Commission:

Firstly, citizens have the right to choose and be reimbursed for treatment, either public health care or private health care, anywhere in the EU.


Secondly, prior authorisations for cross-border healthcare will become the exception rather than the rule.

 

Finally, citizens have the right to make informed decisions about treatment options. They entitled to receive any relevant information from national contact points, established under the new Directive, and information from health care and treatment providers directly.